Bioperfectus

What Bioperfectus does

BioPerfectus (Jiangsu BioPerfectus Technologies Co., Ltd., SSE: 688399) is a publicly listed Chinese molecular diagnostics company founded in 2010 that develops and manufactures PCR-based in vitro diagnostic solutions for clinical laboratories worldwide. Its product platform spans automated nucleic acid extraction workstations (SAW-48, SAW-96, SSNP-2000B, SMPE-960), real-time PCR instruments (STC-96A PLUS), and over 100 CE-marked real-time PCR assays covering infectious diseases (respiratory, vector-borne, gastrointestinal, zoonotic, bloodborne pathogens), sexually transmitted infections, HPV and cervical cancer screening, and prenatal and neonatal care. The company bundles hardware, reagents, and consumables into integrated solutions such as the Total PCR Solution, HPV & Cervical Cancer Screening Solution, Influenza Total Solution, STI Diagnostics Solution, and an Mpox Diagnostic Solution recommended by Africa CDC and the Global Fund.

The business model combines hardware sales (automated workstations and PCR instruments) with recurring consumables and assay revenue (PCR kits, nucleic extraction reagents, rapid antigen tests). With 800+ employees — more than 24% in R&D — and manufacturing centered at the Taizhou Industrial Park in Jiangsu, BioPerfectus operates a vertically integrated R&D-to-production footprint. Commercial reach is delivered through ten wholly-owned subsidiaries in Hong Kong, the USA, Indonesia, Brazil, and Germany, a regional headquarters in Shanghai, a sales and marketing office in Natick, MA, and a US/Canada e-commerce storefront at bplabline.us, giving it stated distribution in 100+ countries. The company pursues an enterprise field sales motion targeting clinical laboratories globally, with no publicly disclosed pricing.

Strategically, BioPerfectus is positioned as a mid-tier Chinese IVD player seeking to expand internationally through multi-jurisdictional regulatory clearances (CE, IVDR, CE-IVD, NMPA), targeted product launches in women's health and STI segments, and public-health procurement validation. There is no disclosed AI/ML capability layer; the company's differentiation rests on proprietary workflow automation, regulatory breadth, assay menu depth, and global subsidiary distribution rather than software or data-driven moats.

Name

Bioperfectus

Legal name

Jiangsu BioPerfectus Technologies Co., Ltd.

Website

https://bioperfectus.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BioPerfectus is a publicly listed Chinese molecular diagnostics company that develops PCR kits, automated nucleic acid extraction workstations, and RT-PCR instruments for clinical laboratories worldwide, with 100+ CE-marked assays across infectious diseases, STI, HPV, and prenatal/neonatal testing distributed through 10 subsidiaries in 100+ countries.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industries

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Infectious Disease POCT (Respiratory, STI, HIV, Sepsis) (HLAHAOAA)

Keywords

• Molecular diagnostics solutions
• PCR testing products
• Nucleic acid extraction systems
• Infectious disease diagnostics
• Women's health diagnostics

Headquarters

HQ city

Taizhou

HQ country

China

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Molecular Diagnostics Products: BioPerfectus generates revenue through manufacturing and selling molecular diagnostics products including PCR kits, nucleic acid extraction systems, automated workstations, and PCR instruments for clinical laboratory testing.
2. In Vitro Diagnostic Solutions: Provides integrated in vitro diagnostic solutions across assays, instruments, and molecular testing workflows for infectious diseases and women's and children's health.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Bioperfectus manufactures and sells integrated molecular diagnostics products for clinical laboratories, including automated nucleic acid extraction workstations (SAW-48, SAW-96, SSNP-2000B, SMPE-960), real-time PCR instruments (STC series), and over 100 CE-marked real-time PCR assay kits. The portfolio spans infectious disease testing (respiratory, vector-borne, gastrointestinal, bloodborne, zoonotic), HPV and cervical cancer screening, STI diagnostics, influenza, and prenatal/neonatal care. The company also offers NGS, POCT, and sample-handling systems, with key product solutions including the Total PCR Solution, HPV&Cervical Cancer Screening Solution, Influenza Total Solution, and STI Diagnostics Solution.

Product overview

BioPerfectus is a global molecular diagnostics company providing integrated solutions for infectious diseases and women's and children's health. The portfolio is organized as platform solutions combined with specialized product lines: (1) Total PCR Solution combining SAW automated extraction workstations with STC series RT-PCR instruments offering 100+ CE-marked real-time PCR assays; (2) HPV&Cervical Cancer Screening Solution with quantitative HPV genotyping and cell preservation; (3) Influenza Total Solution from rapid tests to PCR; (4) STI Diagnostics Solution including multiplex PCR and rapid antigen tests; (5) Prenatal&Neonatal Care products including CMV, EBV, GBS, SMA and fFN tests; (6) EZiCare for self-sampling women's health monitoring; and (7) Systems including automated extraction workstations (SAW-48, SAW-96, SMPE-960, SSNP-2000B), RT-PCR instruments, NGS, POCT, and Sample Handlers. The company also offers disease-specific testing across Respiratory, Vector-Borne, Gastrointestinal, Zoonosis, and Bloodborne categories.

Differentiator

Problem solved

Functional benefit

Products and services

• SAW-48 Automated Nucleic Acid Extraction Workstation Automated walk-away workstation for nucleic acid extraction and PCR reaction setup, processing 1-48 samples. Designed for clinical laboratories with moderate sample throughput, featuring a compact 0.35 m³ form factor.
• SAW-96 Automated Nucleic Acid Extraction Workstation Automated walk-away system for high-throughput nucleic acid extraction workflows, processing larger sample volumes for clinical laboratory use.
• Nucleic Acid Extraction System SSNP-2000B Automated nucleic acid extraction system designed for clinical laboratory use.
• Nucleic Acid Extraction System SMPE-960 High-throughput automated nucleic acid extraction system for clinical laboratory workflows.
• STC-96A PLUS Real-Time PCR System Advanced RT-PCR system forming part of the Total PCR Solution, enabling real-time PCR amplification and detection for clinical molecular diagnostics.
• Total PCR Solution Integrated PCR workflow combining SAW automated walk-away extraction system and STC series RT-PCR system, requiring less than 1 hour of daily hands-on time with only 3 interactions. Includes over 100 CE-marked real-time PCR assays.
• HPV & Cervical Cancer Screening Solution Comprehensive solution for women's health featuring groundbreaking quantitative HPV genotyping detection for cervical cancer screening.
• Influenza Total Solution Comprehensive flu diagnostic test portfolio ranging from rapid tests to Real-Time PCR kits for influenza virus detection.
• STI Diagnostics Solution Solution for asymptomatic STI screening, including multiplex PCR technologies for detecting multiple sexually transmitted infections simultaneously.
• Mpox Diagnostic Solution Diagnostic solution for mpox virus detection, recommended by Africa CDC and the Global Fund for global public health efforts.
• Human Cytomegalovirus Quantitation Real Time PCR Kit In vitro PCR assay for detecting and quantitating cytomegalovirus (CMV) DNA in human urine and serum, assisting in diagnosing CMV congenital infection, CMV hepatitis, CMV pneumonia, and immunosuppressed symptomatic infection. IVDR certified.
• Epstein-Barr Virus Quantitation Real Time PCR Kit Real-time PCR assay for detecting and quantitating EBV DNA, used for diagnosing infectious mononucleosis, chronic active EBV infection, EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH), and X-linked lymphoproliferative syndrome.
• Group B Streptococcus Real Time PCR Kit Real-time PCR kit for detecting Group B Streptococcus (GBS), a leading cause of neonatal and infant sepsis and meningitis. CE-IVD certified.
• Fetal Fibronectin (fFN) Rapid Test Kit Rapid, membrane-based immuno-chromatographic test for qualitative detection of fetal Fibronectin (fFN) in vaginal secretion samples, used as an aid in diagnosis of preterm birth. Results within 15 minutes. CE/NMPA certified.
• Neisseria Gonorrhoeae/Chlamydia Trachomatis/U. Urealyticum Real Time PCR Kit Multiplex real-time PCR kit for simultaneous detection of three STD pathogens: Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
• Mycoplasma Hominis Real Time PCR Kit Real-time PCR kit for detection of Mycoplasma hominis, one of the most common pathogens causing urinary tract infections and genital inflammation.
• Treponema Pallidum Real Time PCR Kit Real-time PCR kit for detection of Treponema pallidum, the pathogen causing syphilis.
• Herpes Simplex Virus Type I/II Real Time PCR Kit Real-time PCR kit for detection of both Herpes Simplex Virus type I and type II (DNA viruses that cause herpes infections).
• Trichomonas Vaginalis Real Time PCR Kit Real-time PCR kit for detection of Trichomonas vaginalis, the parasite causing trichomoniasis, a common treatable STD.
• Candida Albicans/Trichomonas Vaginalis Antigen Rapid Test Kit Rapid antigen test for qualitative detection of Candida albicans and/or Trichomonas vaginalis antigens in vaginal swabs. Results in less than 15 minutes.
• Human Papillomavirus Genotyping Real Time PCR Kit Real-time PCR kit for HPV genotyping, detecting highrisk HPV types that can cause cervical cancer.
• Human Papillomavirus (18 Types) Real Time PCR Kit In-vitro qualitative detection of nucleic acids of 18 HPV types including comprehensive detection and precise genotyping for types 16, 18, 31, 33/58, 45, and 52.
• Cell Preservation Solution Product used for preservation and transport of human cervical exfoliated cells. Cell samples can be stored up to 14 days. Core component of liquid-based cell reagents. IVDR certified.
• EZiCare Pad Self-sampling medical pad for women's health monitoring. Women can observe pH value changes to monitor if healthy, designed for non-invasive HPV sampling and vaginal microbiota testing.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Africa CDCcoreStrategic or Co-development Partner · 1 March 2024Africa CDC recommended BioPerfectus mpox diagnostic solutions as part of global public health efforts to combat mpox outbreaks. This endorsement highlights the company's role in supporting international health organizations.
• Global FundcoreStrategic or Co-development Partner · 1 March 2024Global Fund recommended BioPerfectus mpox diagnostic solutions for global public health efforts. The partnership validates BioPerfectus's diagnostic capabilities for pandemic preparedness.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BGI Genomics: A Chinese molecular diagnostics and sequencing peer offering PCR, NGS, and women's health testing; comparable to BioPerfectus across molecular infectious disease and HPV/cervical cancer screening.
• Sansure Biotech: A Chinese molecular diagnostics peer offering automated nucleic acid extraction and a broad PCR kit menu across infectious disease and women's health; directly competes with BioPerfectus in domestic and emerging markets.
• QIAGEN: A direct molecular diagnostics and sample-preparation peer with the QIAcube/QIAsymphony extraction instruments and a broad PCR/NGS consumables menu — comparable to BioPerfectus's SAW extraction workstations and assay portfolio.
• Hologic: A direct peer in molecular diagnostics with the Panther system and Aptima assays for women's health (HPV, CT/NG, trichomonas) — directly competing with BioPerfectus's STI and HPV cervical cancer screening solutions.
• DAAN Gene (Hybio Pharmaceutical): A Chinese molecular diagnostics peer with real-time PCR kits and nucleic acid extraction systems; highly comparable as a domestic competitor in China's IVD market.
• Cepheid (Danaher): A direct molecular diagnostics peer offering the GeneXpert real-time PCR system and an extensive Xpert test menu for infectious disease, STI, and women's health — directly comparable to BioPerfectus's Total PCR Solution and assay portfolio.

Regional players

• Autobio Diagnostics: A Chinese IVD peer with molecular, immunoassay, and microbiology product lines competing primarily in the Chinese market; comparable as a regional player in IVD.

Emerging players

• Molbio Diagnostics: An emerging player in point-of-care molecular diagnostics with the Truelab real-time PCR platform; an emerging-market comparator relevant to BioPerfectus's POCT and outbreak-response use cases.

Broad incumbents

• Abbott Molecular: Broad incumbent offering the m2000 and Alinity m molecular platforms with real-time PCR assays across infectious disease and STI; competes with BioPerfectus in global clinical laboratory accounts.
• Roche Diagnostics: Broad incumbent in in-vitro diagnostics with the cobas molecular systems and a leading PCR test menu across infectious disease, HPV, and STI; competes with BioPerfectus across the same clinical lab customer base globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/PerfectusBio

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioperfectus